Platinum Sensitive Small Cell Lung Cancer (SCLC)
Also known as: Platinum-Sensitive Lung Small Cell Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB12887 | Tazemetostat | 1 | Recruiting | 1 |
| DB01030 | Topotecan | 1 | Recruiting | 1 |
| DB11794 | Berzosertib | 2 | Active Not Recruiting | 1 |
| DB00958 | Carboplatin | 2 | Recruiting | 1 |
| DB11714 | Durvalumab | 2 | Recruiting | 2 |
| DB00773 | Etoposide | 2 | Recruiting | 1 |
| DB12674 | Lurbinectedin | 2 | Recruiting | 2 |
| DB01030 | Topotecan | 2 | Active Not Recruiting | 1 |